Abstract

IntroductionDespite improvement in progression-free survival with poly (ADP-ribose) polymerase inhibitors (PARPi) as maintenance therapy for ovarian cancer, many patients will eventually progress on therapy. Oligoprogression is uniquely suited to considerations...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
PARP inhibitor and chemotherapy combination trials for the treatment of advanced malignancies: does a development pathway forward exist?
U.A Matulonis ... B.J Monk
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 28
U.A Matulonis, et. al.U.A Matulonis ... B.J Monk
01 Mar 2017
31P Survival outcomes in BRCA pathogenetic mutated, variant of unknown significance, and wild type ovarian cancer patients treated with PARP inhibitors
L Musacchio ... D Lorusso
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 33
L Musacchio, et. al.L Musacchio ... D Lorusso
01 Jun 2022
2022-RA-1103-ESGO Poly ADP ribose polymerase inhibitors as maintenance therapy for ovarian cancer: Uncovering clinical gaps in physician knowledge and approaches to clinical practice
Ben Johnson ... Juliette Vandenbroucque
-
Ben Johnson, et. al.Ben Johnson ... Juliette Vandenbroucque
01 Oct 2022
Efficacy and safety of PARP inhibitors as the maintenance therapy in ovarian cancer: a meta-analysis of nine randomized controlled trials.
Fengping Shao ... Jun Liu
Bioscience reports | VOL. 40
Fengping Shao, et. al.Fengping Shao ... Jun Liu
18 Mar 2020
View more papers

More From: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Paper Title
Journal
Date
Author
Secondary databases in gynecologic cancer research
Katherine Hicks-Courant ... Pedro T Ramirez
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Katherine Hicks-Courant, et. al.Katherine Hicks-Courant ... Pedro T Ramirez
23 Jul 2024
Cervical cancer and risk of dementia: real-world insights from a nationwide cohort study in Taiwan
Siou-Ting Lee ... Nian-Sheng Tzeng
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Siou-Ting Lee, et. al.Siou-Ting Lee ... Nian-Sheng Tzeng
23 Jul 2024
DNA methylation detection is a significant biomarker for screening endometrial cancer in premenopausal women with abnormal uterine bleeding
Xingping Zhao ... Dabao Xu
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Xingping Zhao, et. al.Xingping Zhao ... Dabao Xu
23 Jul 2024
Best original research presented at the 25th European Congress on Gynaecological Oncology: best of ESGO 2024
Joanna Kacperczyk-Bartnik ... Domenica Lorusso
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Joanna Kacperczyk-Bartnik, et. al.Joanna Kacperczyk-Bartnik ... Domenica Lorusso
20 Jul 2024
View more papers